Prosecuting Pharmaceutical Fraud

Pharmaceutical fraud involves the illegal manufacture, promotion, and sale of drugs that are subsidized or reimbursed by the government through federally funded healthcare programs such as Medicare, Medicaid, or Tricare. Pharmaceutical companies commit fraud and profit illegally in a number of ways:

• Adulterating drugs or deliberately avoiding manufacturing regulations
• Misrepresenting the safety and efficacy of drugs to federal regulators
• Promoting drugs for uses that the Food and Drug Administration has not approved
• Providing financial incentives to doctors to prescribe certain drugs
• Overcharging federal healthcare programs for drugs

Pharmaceutical fraud endangers patients, erodes trust between healthcare providers and patients, increases healthcare costs, and wastes billions of taxpayer dollars annually. Pharmaceutical whistleblowers who come forward with information about fraudulent drug practices help reduce the government’s and taxpayers’ healthcare losses, and keep the pharmaceutical marketplace safe for doctors, patients, and consumers.